| Financial Year |
March 31 2023 |
| Monetary Funds |
159,649,549.22 |
| Held-for-trading Financial Assets |
30,034,002.74 |
| Notes Receivable |
60,336,056.28 |
| Accounts Receivable |
31,816,069.31 |
| Advances to Suppliers |
28,641,937.54 |
| Other Receivables |
20,436,067.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
74,146,767.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
580,982,466.93 |
| Total Current Assets |
1,030,411,685.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
316,037,135.83 |
| Under-construction Projects |
526,014,549.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,485,260.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,073,656.85 |
| Other Non-Current Assets |
35,038,985.89 |
| Sub-Total of Non-Current Assets |
1,118,683,156.27 |
| Total Assets |
2,149,094,841.73 |
| Short-Term Loans |
49,789,507.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
118,100,416.38 |
| Accounts Payable |
114,509,282.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
165,134.80 |
| Taxes Payable |
5,103,032.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,074,300.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,140,000.00 |
| Other Current Liabilities |
36,319,711.36 |
| Sub-Total of Current Liabilities |
355,895,087.18 |
| Long-term Loans |
244,588,587.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
420,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,956,849.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
297,047,605.98 |
| Total Liabilities |
652,942,693.16 |
| Paid-In Capital(Or Share Stock) |
106,670,000.00 |
| Capital Surplus |
684,607,114.13 |
| Surplus Reserve |
73,501,205.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
612,266,863.72 |
| Minority Stockholder's Interest |
3,244,416.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,492,907,732.39 |
| Owner's Equity（Stockholder's Equity） |
1,496,152,148.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,149,094,841.73 |
